Description
Description
Ryzodeg Penfill 3ml 5's (100U/ml) is a, produced by Novo Nordisk, soluble formulation containing a mixture of insulin degludec (basal) and insulin aspart (rapid-acting).
It is designed for treating diabetes mellitus to improve glycemic control by providing both long-acting and mealtime insulin coverage in one injection.
Key Information:
Composition: Each 3ml penfill contains Insulin Degludec 70% and Insulin Aspart 30 %.
Usage:
Used for adults with diabetes mellitus needing insulin therapy.
Storage: Store in a refrigerator; do not freeze. Once in use, it can be kept at room temperature for a limited time.
Administration: Used with a compatible insulin pen (e.g., FlexTouch) for subcutaneous injection.
Side Effects: Potential for hypoglycemia (low blood sugar), injection site reactions, and weight gain.
Pack Size: Available in a pack of 5 cartridges (5 x 3ml).
Disclaimer: Consult a doctor for dosage and before using this medication.



